Edition:
India

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

6.89USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$6.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
121,435
52-wk High
$7.59
52-wk Low
$0.91

Select another date:

Thu, Apr 5 2018

BRIEF-CASI Pharma Says Advisory Committee to Review Evomela Between April 25-26

* CASI PHARMACEUTICALS - RECEIPT OF LETTER FROM CENTER FOR DRUG EVALUATION FOR INJECTION SCHEDULED FOR REVIEW BY ADVISORY COMMITTEE

BRIEF-CASI Pharmaceuticals Q4 Loss Per Share $0.08

* CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-CASI Pharmaceuticals Announces $50 Million Private Placement

* CASI PHARMACEUTICALS ANNOUNCES $50 MILLION PRIVATE PLACEMENT TO PREPARE COMPANY FOR COMMERCIALIZATION IN CHINA

BRIEF-Casi Pharmaceuticals Enters Into A Common Stock Sales Agreement With H.C. Wainwright & Co

* CASI PHARMACEUTICALS INC SAYS ENTERED INTO A COMMON STOCK SALES AGREEMENT WITH H.C. WAINWRIGHT & CO LLC - SEC FILING

BRIEF-CASI Pharma Board Approves Appointment Of Wei-Wu He As Executive Chairman

* CASI PHARMACEUTICALS - ON FEB 7, BOARD APPROVED APPOINTMENT OF WEI-WU HE, CURRENT CHAIRMAN OF BOARD, AS EXECUTIVE CHAIRMAN - SEC FILING Source text: (http://bit.ly/2EUtR7g) Further company coverage:

BRIEF-Casi Pharmaceuticals Files For Stock Shelf Of Upto $100 Million

* CASI PHARMACEUTICALS INC FILES FOR STOCK SHELF OF UPTO $100 MILLION - SEC FILING Source text: [http://bit.ly/2zaieHQ] Further company coverage:

BRIEF-Casi pharmaceuticals Q3 loss per share $0.03

* Casi Pharmaceuticals reports third quarter 2017 financial results

Select another date: